Skip to content

Clinical trials

Terminated Phase 3 Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20092
20112
20132
20141
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston University1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Hamilton Health Sciences Corporation1
Idorsia Pharmaceuticals Ltd.1
McMaster University1
Medical University of Vienna1
National Cancer Center, Korea1
Population Health Research Institute1
The Medicines Company1
University Hospital, Angers1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage11
Arrhythmias, Cardiac1
Atrial Fibrillation1
Blood Loss, Surgical1
Bone Neoplasms1
Cardiovascular Diseases1
Craniocerebral Trauma1
Critical Illness1
Renal Insufficiency, Chronic1
Seizures1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.